{
  "experiment_id": "f916c86b0143",
  "timestamp": "2025-11-12T13:04:20.926011",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "task_results": {
    "broadening_of_narrow_synonyms": {
      "task_name": "broadening_of_narrow_synonyms",
      "num_samples": 10,
      "results": [
        {
          "sample_index": 0,
          "input": {
            "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
            "assay": "clinical whole-exome sequencing",
            "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1 microdeletion syndrome\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\" \n   - Broadened from the narrow, specific term to the standard controlled vocabulary term that encompasses clinical applications\n\n2. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\"\n   - Removed the parenthetical qualifier \"(morphologic abnormality)\" and standardized the capitalization to match the controlled vocabulary\n\n3. **diagnosis**: No change needed - \"Neurofibromatosis type 1 microdeletion syndrome\" is already appropriately specific and doesn't have a broader standard term in this context",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2837,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 225
            },
            "attempt": 1
          },
          "score": 0.02564102564102564,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Plexiform Neurofibroma"
          }
        },
        {
          "sample_index": 1,
          "input": {
            "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
            "assay": "Illumina whole exome sequencing ",
            "tumorType": "malignant triton tumor"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1 with optic pathway glioma\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **assay**: \"Illumina whole exome sequencing\" \u2192 \"whole exome sequencing\"\n   - Broadened from platform-specific term (Illumina) to the general standard assay type\n   - Removed trailing whitespace\n\n2. **tumorType**: \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Malignant triton tumor is a rare, specific subtype of MPNST (characterized by rhabdomyoblastic differentiation)\n   - Broadened to the more general, standard term that encompasses this specific variant\n   - Corrected capitalization to match controlled vocabulary\n\n3. **diagnosis**: No change needed - already uses appropriate terminology",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2832,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 244
            },
            "attempt": 1
          },
          "score": 0.056179775280898875,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 2,
          "input": {
            "diagnosis": "Watson Syndrome",
            "assay": "MGI whole genome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Watson Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Broadened from platform-specific term (MGI) to the standard general assay type\n\n2. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Broadened from specific subtype to the standard general tumor type category\n\n3. **diagnosis**: \"Watson Syndrome\" - No change needed as this is already an appropriate diagnostic term",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2831,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 192
            },
            "attempt": 1
          },
          "score": 0.07352941176470588,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole genome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 3,
          "input": {
            "diagnosis": "neurofibromatosis, familial spinal",
            "assay": "open MRI",
            "tumorType": "unknown - no information available"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"neurofibromatosis\" - Broadened from a specific subtype to the general diagnosis term.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\" - \"Open MRI\" is a specific type of MRI scanner configuration. The broader, standard term from the controlled vocabulary is \"conventional MRI\".\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\" - Standardized to match the exact controlled vocabulary term \"Unknown\" (with capital U and no additional descriptive text).",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2819,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 188
            },
            "attempt": 1
          },
          "score": 0.014084507042253521,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 4,
          "input": {
            "diagnosis": "Not Applicable",
            "assay": "immunohistochemistry of skin",
            "tumorType": "Cutaneous storiform neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **assay**: \"immunohistochemistry of skin\" \u2192 \"immunohistochemistry\"\n   - Broadened the narrow, tissue-specific term to the standard general assay term from the controlled vocabulary\n\n2. **tumorType**: \"Cutaneous storiform neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Broadened the specific histological subtype (\"storiform\") to the standard broader category from the controlled vocabulary\n\n3. **diagnosis**: \"Not Applicable\" remained unchanged as it matches the controlled terminology",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2819,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 180
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Not Applicable",
            "assay": "immunohistochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 5,
          "input": {
            "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
            "assay": "cell viability assay using Annexin V staining",
            "tumorType": "Pedunculated Cutaneous Neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"chromosome 17q11.2 deletion syndrome, 1.4Mb\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: No change needed - this is already appropriately specific for the condition being described.\n\n2. **assay**: Broadened from \"cell viability assay using Annexin V staining\" to \"cell viability assay\" - the specific method (Annexin V staining) is a narrow implementation detail, while \"cell viability assay\" is the standard broader term in the controlled vocabulary.\n\n3. **tumorType**: Broadened from \"Pedunculated Cutaneous Neurofibroma\" to \"Cutaneous Neurofibroma\" - \"Pedunculated\" is a morphological descriptor that makes the term overly specific. The controlled vocabulary includes \"Cutaneous Neurofibroma\" as the standard broader term.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2841,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 239
            },
            "attempt": 1
          },
          "score": 0.011764705882352941,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "cell viability assay",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 6,
          "input": {
            "diagnosis": "Neurofibromatosis type 1 with scoliosis",
            "assay": "anti-tag immunocytochemistry",
            "tumorType": "sessile cutaneous neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1 with scoliosis\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: No change needed - \"Neurofibromatosis type 1 with scoliosis\" is appropriately specific and doesn't require broadening.\n\n2. **assay**: \"anti-tag immunocytochemistry\" \u2192 \"immunocytochemistry\"\n   - The narrow, specific term describing a particular variant (anti-tag) has been broadened to the standard general assay type that exists in the controlled vocabulary.\n\n3. **tumorType**: \"sessile cutaneous neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - The narrow descriptor \"sessile\" (referring to the growth pattern) has been removed to match the broader, standard term in the controlled vocabulary.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2832,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 231
            },
            "attempt": 1
          },
          "score": 0.012658227848101266,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "immunocytochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 7,
          "input": {
            "diagnosis": "neurofibromatosis, peripheral type",
            "assay": "wide bore MRI",
            "tumorType": "no clear diagnosis"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"neurofibromatosis type 1\" \n   - Peripheral neurofibromatosis is the older terminology for NF1, which is the standard modern term.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Wide bore MRI is a specific scanner configuration (larger opening), but the imaging technique itself is conventional MRI. The broader, standard term is \"conventional MRI\".\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - \"Unknown\" is the standard controlled vocabulary term from the schema that corresponds to cases where there is no clear diagnosis or the tumor type cannot be determined.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2816,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 218
            },
            "attempt": 1
          },
          "score": 0.011494252873563218,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 8,
          "input": {
            "diagnosis": "acoustic neurofibromatosis",
            "assay": "RNA-seq with ribosomal RNA depletion",
            "tumorType": "Acoustic neuroma of left vestibular nerve"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 2\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"neurofibromatosis type 2\"\n   - Acoustic neurofibromatosis is a narrow/outdated term for NF2 (neurofibromatosis type 2), which is characterized by bilateral vestibular schwannomas.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The specific technical detail about ribosomal RNA depletion is a narrow descriptor of the RNA-seq methodology. The broader, standard term from the controlled vocabulary is \"RNA-seq\".\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - \"Acoustic neuroma\" is an outdated/narrow term for vestibular schwannoma. The broader, standard term in the controlled vocabulary is \"Schwannoma\". The anatomical location detail (left vestibular nerve) is also removed to match the controlled terminology.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2829,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 288
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "NF2-related schwannomatosis",
            "assay": "RNA-seq",
            "tumorType": "schwannoma"
          }
        },
        {
          "sample_index": 9,
          "input": {
            "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
            "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
            "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to \"neurofibromatosis type 1\" - removed the specific molecular mechanism details to use the standard general diagnosis term.\n\n2. **assay**: Mapped \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to \"3D microtissue viability\" - this is the broader, standardized term for 3D cell viability assays in the controlled vocabulary.\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" (a specific histological subtype) to \"Malignant Peripheral Nerve Sheath Tumor\" - the general tumor type available in the controlled vocabulary.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2862,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 262
            },
            "attempt": 1
          },
          "score": 0.06097560975609756,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "3D microtissue viability",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        }
      ],
      "metrics": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.026632751608899892,
        "min_score": 0.0,
        "max_score": 0.07352941176470588,
        "num_scored": 10
      }
    },
    "correction_of_typos": {
      "task_name": "correction_of_typos",
      "num_samples": 10,
      "results": [
        {
          "sample_index": 0,
          "input": {
            "diagnosis": "neruofibromatosis type 1",
            "assay": "whole exme squencing",
            "tumorType": "Plexifform Neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Corrections made:**\n1. `\"neruofibromatosis type 1\"` \u2192 `\"neurofibromatosis type 1\"` (fixed typo: \"neruo\" to \"neuro\")\n2. `\"whole exme squencing\"` \u2192 `\"whole exome sequencing\"` (fixed typos: \"exme\" to \"exome\" and \"squencing\" to \"sequencing\"; matched to controlled terminology)\n3. `\"Plexifform Neurofibroma\"` \u2192 `\"Plexiform Neurofibroma\"` (fixed typo: \"Plexifform\" to \"Plexiform\"; matched to controlled terminology)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2821,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 215
            },
            "attempt": 1
          },
          "score": 0.03571428571428571,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Plexiform Neurofibroma"
          }
        },
        {
          "sample_index": 1,
          "input": {
            "diagnosis": "neurofibromatosis type !",
            "assay": "whole exme seq",
            "tumorType": "Malignant Periferal Nerve Sheath Tumor"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n1. **diagnosis**: \"neurofibromatosis type !\" \u2192 \"neurofibromatosis type 1\" (corrected \"!\" to \"1\")\n2. **assay**: \"whole exme seq\" \u2192 \"whole exome sequencing\" (corrected \"exme seq\" to \"exome sequencing\" and matched to controlled terminology)\n3. **tumorType**: \"Malignant Periferal Nerve Sheath Tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" (corrected \"Periferal\" to \"Peripheral\")",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2823,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 202
            },
            "attempt": 1
          },
          "score": 0.09259259259259259,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 2,
          "input": {
            "diagnosis": "neurofibromatisis type 1",
            "assay": "whle genome squencing",
            "tumorType": "Maliggnant Peripheral Nerve Sheath Tumor"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2824,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 61
            },
            "attempt": 1
          },
          "score": 0.18518518518518517,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole genome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 3,
          "input": {
            "diagnosis": "FN1",
            "assay": "conventonal MRI",
            "tumorType": "unknwon"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"NF1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n1. `\"FN1\"` \u2192 `\"NF1\"` (corrected typo in diagnosis)\n2. `\"conventonal MRI\"` \u2192 `\"conventional MRI\"` (corrected spelling: \"conventonal\" to \"conventional\")\n3. `\"unknwon\"` \u2192 `\"Unknown\"` (corrected spelling and capitalization to match controlled terminology)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2806,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 134
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 4,
          "input": {
            "diagnosis": "Not Aplicabble",
            "assay": "immunohistochemsitry",
            "tumorType": "Cutaneous Neuroffibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2816,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 51
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Not Applicable",
            "assay": "immunohistochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 5,
          "input": {
            "diagnosis": "meurofibromatosis type 1",
            "assay": "cell viabilty assay",
            "tumorType": "Cutaneous Neurfibromaa"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n1. **diagnosis**: \"meurofibromatosis type 1\" \u2192 \"neurofibromatosis type 1\" (fixed typo: \"meurofibro\" \u2192 \"neurofibro\")\n2. **assay**: \"cell viabilty assay\" \u2192 \"cell viability assay\" (fixed typo: \"viabilty\" \u2192 \"viability\", matched controlled terminology)\n3. **tumorType**: \"Cutaneous Neurfibromaa\" \u2192 \"Cutaneous Neurofibroma\" (fixed typos: \"Neurfibromaa\" \u2192 \"Neurofibroma\", matched controlled terminology)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2820,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 208
            },
            "attempt": 1
          },
          "score": 0.04,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "cell viability assay",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 6,
          "input": {
            "diagnosis": "neurofbiromatosis tpye 2",
            "assay": "immunocytochemsitry",
            "tumorType": "Cutanneous Neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 2\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2822,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 57
            },
            "attempt": 1
          },
          "score": 0.047619047619047616,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "immunocytochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 7,
          "input": {
            "diagnosis": "Neurofibromatosis type 47",
            "assay": "conventioal MRI",
            "tumorType": "un known"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 47\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n1. **assay**: \"conventioal MRI\" \u2192 \"conventional MRI\" (fixed typo: \"conventioal\" to \"conventional\")\n2. **tumorType**: \"un known\" \u2192 \"Unknown\" (fixed spacing and capitalization to match controlled terminology)\n3. **diagnosis**: Left as-is since \"Neurofibromatosis type 47\" appears to be the intended diagnosis (note: this is unusual as typically NF1 is \"type 1\" and NF2 is \"type 2\", but I preserved the original meaning as instructed)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2813,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 184
            },
            "attempt": 1
          },
          "score": 0.014084507042253521,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 8,
          "input": {
            "diagnosis": "NF@-related schwannomatosis",
            "assay": "RNA-seque",
            "tumorType": "Schwannomaa"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2814,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 51
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "NF2-related schwannomatosis",
            "assay": "RNA-seq",
            "tumorType": "schwannoma"
          }
        },
        {
          "sample_index": 9,
          "input": {
            "diagnosis": "nf1",
            "assay": "#D microtissue viability",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumorr"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"NF1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n1. **diagnosis**: \"nf1\" \u2192 \"NF1\" (proper capitalization)\n2. **assay**: \"#D microtissue viability\" \u2192 \"3D microtissue viability\" (corrected \"#D\" to \"3D\")\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumorr\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" (removed extra \"r\")",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2821,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 172
            },
            "attempt": 1
          },
          "score": 0.08333333333333333,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "3D microtissue viability",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        }
      ],
      "metrics": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.04985289514866979,
        "min_score": 0.0,
        "max_score": 0.18518518518518517,
        "num_scored": 10
      }
    },
    "narrowing_of_broad_synonyms": {
      "task_name": "narrowing_of_broad_synonyms",
      "num_samples": 10,
      "results": [
        {
          "sample_index": 0,
          "input": {
            "diagnosis": "Neurofibromatosis",
            "assay": "DNA sequencing",
            "tumorType": "Neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Rationale for corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis\" - Kept as is since this is already a specific diagnosis term and no more specific variant was indicated in the context.\n\n2. **assay**: \"DNA sequencing\" \u2192 \"whole genome sequencing\" - The broad term \"DNA sequencing\" was narrowed to the more specific \"whole genome sequencing\", which is the most comprehensive DNA sequencing method in the controlled vocabulary. Alternative specific options could include \"whole exome sequencing\" or \"targeted sequencing\" depending on the actual experimental context.\n\n3. **tumorType**: \"Neurofibroma\" \u2192 \"Plexiform Neurofibroma\" - The general term \"Neurofibroma\" was narrowed to \"Plexiform Neurofibroma\", which is the most clinically significant subtype in neurofibromatosis. Other valid specific options from the schema include \"Cutaneous Neurofibroma\", \"Subcutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Nodular Neurofibroma\", \"Diffuse Infiltrating Neurofibroma\", \"Cellular Neurofibroma\", \"Atypical Neurofibroma\", or \"Massive Soft Tissue Neurofibroma\" - the choice of \"Plexiform Neurofibroma\" reflects its common association with neurofibromatosis type 1.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2814,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 378
            },
            "attempt": 1
          },
          "score": 0.018518518518518517,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Plexiform Neurofibroma"
          }
        },
        {
          "sample_index": 1,
          "input": {
            "diagnosis": "NF",
            "assay": "exome sequencing",
            "tumorType": "sarcoma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" is a broad abbreviation that has been narrowed to \"neurofibromatosis\" - the full, more specific term for this condition.\n\n2. **assay**: \"exome sequencing\" is a general term that has been narrowed to \"whole exome sequencing\" - the precise terminology from the controlled vocabulary that specifies the complete exome is being sequenced.\n\n3. **tumorType**: \"sarcoma\" has been corrected to \"Sarcoma\" to match the exact capitalization in the controlled terminology enum (maintaining consistency with the schema's controlled vocabulary).",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2808,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 192
            },
            "attempt": 1
          },
          "score": 0.012987012987012988,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 2,
          "input": {
            "diagnosis": "Neurofibromatoses",
            "assay": "assay by high throughput sequencer",
            "tumorType": "Nerve Sheath Neoplasm"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis Type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Rationale for corrections:**\n\n1. **diagnosis**: \"Neurofibromatoses\" (plural, broad term) \u2192 \"Neurofibromatosis Type 1\" - Narrowed to the most common specific type (NF1), which is the primary focus of the controlled terminology schema (as evidenced by NF1-Associated Tumor and NF2-Associated Tumor distinctions).\n\n2. **assay**: \"assay by high throughput sequencer\" (broad, generic term) \u2192 \"whole genome sequencing\" - This is the most common and comprehensive high-throughput sequencing assay in the controlled vocabulary. Alternative narrower terms could include \"whole exome sequencing\" or \"RNA-seq\" depending on specific context, but WGS is the most inclusive sequencing approach.\n\n3. **tumorType**: \"Nerve Sheath Neoplasm\" (broad pathological category) \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" - This is the specific malignant nerve sheath tumor type that appears in the controlled vocabulary and is commonly associated with neurofibromatosis. \"Schwannoma\" and \"Neurofibroma\" are benign alternatives, but MPNST is the most clinically significant nerve sheath neoplasm in this context.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2823,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 351
            },
            "attempt": 1
          },
          "score": 0.0423728813559322,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole genome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 3,
          "input": {
            "diagnosis": "neurocutaneous syndrome",
            "assay": "spectroscopy",
            "tumorType": "unknown"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term encompassing various conditions. Given the context of the controlled terminology (which includes NF1/NF2-associated tumors and neurofibromas), the more specific term \"neurofibromatosis\" is appropriate.\n\n2. **assay**: \"spectroscopy\" is too general. From the controlled vocabulary, \"FTIR spectroscopy\" is the specific spectroscopy method available, making it the appropriate narrower term.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled vocabulary enum.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2808,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 196
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 4,
          "input": {
            "diagnosis": "Not Applicable",
            "assay": "immunoassay",
            "tumorType": "neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"ELISA\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Rationale for changes:**\n\n1. **diagnosis**: \"Not Applicable\" is already specific and matches the controlled vocabulary exactly - no change needed.\n\n2. **assay**: \"immunoassay\" is a broad term that encompasses multiple specific techniques. I narrowed it to \"ELISA\" (Enzyme-Linked Immunosorbent Assay), which is the most common and widely-used immunoassay technique in the controlled vocabulary.\n\n3. **tumorType**: \"neurofibroma\" (lowercase, general term) was narrowed to \"Plexiform Neurofibroma\", which is a specific, clinically significant subtype of neurofibroma commonly associated with NF1. This is a more precise classification that provides greater clinical and research value. Other options in the schema include \"Cutaneous Neurofibroma\", \"Subcutaneous Neurofibroma\", \"Localized Neurofibroma\", etc., but \"Plexiform Neurofibroma\" is the most commonly studied variant in research contexts.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2810,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 282
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Not Applicable",
            "assay": "immunohistochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 5,
          "input": {
            "diagnosis": "neurofibromatosis",
            "assay": "plate based reporter assay",
            "tumorType": "benign neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **assay**: Changed \"plate based reporter assay\" \u2192 \"massively parallel reporter assay\" (the most specific reporter assay term available in the controlled vocabulary)\n\n2. **tumorType**: Changed \"benign neurofibroma\" \u2192 \"Neurofibroma\" (narrowed to the precise controlled term; \"benign\" is implied as Neurofibroma without qualifiers like \"Atypical\" represents the standard benign form)\n\n3. **diagnosis**: Kept \"neurofibromatosis\" as-is (no controlled enum provided for this field, so the term remains unchanged)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2816,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 193
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "cell viability assay",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 6,
          "input": {
            "diagnosis": "RASopathy",
            "assay": "immunoassay",
            "tumorType": "NFIB"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"RASopathy\",\n  \"assay\": \"ELISA\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" - This term is kept as-is since it's already a specific diagnostic category referring to genetic syndromes caused by mutations in the RAS/MAPK pathway (including NF1, Noonan syndrome, etc.). No narrower term is available in the context.\n\n2. **assay**: \"immunoassay\" \u2192 \"ELISA\" - \"Immunoassay\" is a broad category that includes many specific techniques. ELISA (Enzyme-Linked Immunosorbent Assay) is the most common and specific type of immunoassay in the controlled vocabulary.\n\n3. **tumorType**: \"NFIB\" \u2192 \"Neurofibroma\" - \"NFIB\" appears to be a typo or abbreviation. Given the context of RASopathy (which includes NF1), this most likely refers to \"Neurofibroma,\" which is a specific tumor type associated with neurofibromatosis and is present in the controlled vocabulary.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2811,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 284
            },
            "attempt": 1
          },
          "score": 0.01,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "immunocytochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 7,
          "input": {
            "diagnosis": "NF",
            "assay": "medical imaging",
            "tumorType": "unknown"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" is a broad abbreviation that has been expanded to \"Neurofibromatosis\" for clarity and precision.\n\n2. **assay**: \"medical imaging\" is a very broad term. Based on the controlled terminology available and the context of NF (Neurofibromatosis) diagnosis, I've narrowed it to \"conventional MRI\", which is one of the most common and specific imaging modalities used in NF clinical assessment. Other options from the schema could include \"structural MRI\", \"diffusion MRI\", or \"functional MRI\" depending on the specific imaging protocol used.\n\n3. **tumorType**: \"unknown\" has been corrected to \"Unknown\" to match the exact capitalization in the controlled vocabulary enum.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2804,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 220
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 8,
          "input": {
            "diagnosis": "neurocristopathy",
            "assay": "transcriptomics",
            "tumorType": "neurolemmoma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" (a broad term referring to disorders of neural crest-derived tissues) \u2192 \"neurofibromatosis\" (a more specific neural crest disorder that aligns with the tumor types in the controlled vocabulary)\n\n2. **assay**: \"transcriptomics\" (a broad category of gene expression analysis) \u2192 \"RNA-seq\" (a specific transcriptomics method from the controlled vocabulary)\n\n3. **tumorType**: \"neurolemmoma\" (an older/alternative term) \u2192 \"Schwannoma\" (the current standard terminology for this tumor type, present in the controlled vocabulary)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2812,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 197
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "NF2-related schwannomatosis",
            "assay": "RNA-seq",
            "tumorType": "schwannoma"
          }
        },
        {
          "sample_index": 9,
          "input": {
            "diagnosis": "phakomatosis",
            "assay": "viability assay",
            "tumorType": "tumor of cranial and spinal nerves"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term referring to a group of neurocutaneous syndromes. Given the context of the controlled terminology (which includes NF1/NF2-associated tumors and neurofibromas), the more specific term is \"neurofibromatosis\".\n\n2. **assay**: \"viability assay\" is a general term. The controlled vocabulary includes the more specific \"cell viability assay\", which is the standard precise terminology for this type of assay.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical/pathological description. The most appropriate specific term from the controlled vocabulary is \"Schwannoma\", which is the primary tumor type affecting cranial and spinal nerves in the context of neurofibromatosis and related conditions.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2816,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 245
            },
            "attempt": 1
          },
          "score": 0.011363636363636364,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "3D microtissue viability",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        }
      ],
      "metrics": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.009524204922510007,
        "min_score": 0.0,
        "max_score": 0.0423728813559322,
        "num_scored": 10
      }
    },
    "translation_of_exact_synonyms": {
      "task_name": "translation_of_exact_synonyms",
      "num_samples": 10,
      "results": [
        {
          "sample_index": 0,
          "input": {
            "diagnosis": "NF1",
            "assay": "WEX",
            "tumorType": "pNF"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"NF1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2809,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 52
            },
            "attempt": 1
          },
          "score": 0.043478260869565216,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Plexiform Neurofibroma"
          }
        },
        {
          "sample_index": 1,
          "input": {
            "diagnosis": "neurofibromatosis type 1",
            "assay": "WES",
            "tumorType": "MPNST"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2815,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 62
            },
            "attempt": 1
          },
          "score": 0.18518518518518517,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole exome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 2,
          "input": {
            "diagnosis": "ORPHA:636",
            "assay": "WGS",
            "tumorType": "MPN tumor"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"ORPHA:636\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2811,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 57
            },
            "attempt": 1
          },
          "score": 0.15384615384615385,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "whole genome sequencing",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        },
        {
          "sample_index": 3,
          "input": {
            "diagnosis": "Von Recklinghausen's neurofibromatosis",
            "assay": "MRS",
            "tumorType": "NOS"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Von Recklinghausen's neurofibromatosis\",\n  \"assay\": \"magnetic resonance spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Von Recklinghausen's neurofibromatosis\" - This is a historical synonym for Neurofibromatosis Type 1 (NF1). However, since the controlled terminology schema doesn't specify exact diagnosis terms (no enum provided), I've kept the original value as it's a valid medical term.\n\n2. **assay**: \"MRS\" \u2192 \"magnetic resonance spectroscopy\" - MRS is a common abbreviation for magnetic resonance spectroscopy, which is the standard term in the controlled vocabulary.\n\n3. **tumorType**: \"NOS\" \u2192 \"Unknown\" - \"NOS\" (Not Otherwise Specified) is a medical abbreviation indicating that the specific type is not specified. The closest match in the controlled vocabulary is \"Unknown\" rather than the more specific \"High-Grade Glioma NOS\" or \"Low-Grade Glioma NOS\" since no glioma context was provided.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2818,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 275
            },
            "attempt": 1
          },
          "score": 0.009708737864077669,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 4,
          "input": {
            "diagnosis": "does not apply",
            "assay": "IHC",
            "tumorType": "cNF"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2809,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 51
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Not Applicable",
            "assay": "immunohistochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 5,
          "input": {
            "diagnosis": "NF-1",
            "assay": "cell survival assay",
            "tumorType": "dermal neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"NF-1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF-1\" - No change needed as this is an acceptable term for the diagnosis field (which has no controlled vocabulary in the schema).\n\n2. **assay**: \"cell survival assay\" \u2192 \"cell viability assay\" - These are near-exact synonyms in biological research. Cell survival and cell viability assays both measure the proportion of living cells, and \"cell viability assay\" is the standard term in the controlled vocabulary.\n\n3. **tumorType**: \"dermal neurofibroma\" \u2192 \"Cutaneous Neurofibroma\" - Dermal and cutaneous are synonyms (both referring to skin-related), and \"Cutaneous Neurofibroma\" is the standard preferred term in the controlled vocabulary.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2814,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 227
            },
            "attempt": 1
          },
          "score": 0.0125,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "cell viability assay",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 6,
          "input": {
            "diagnosis": "neurofibromatosis 1",
            "assay": "ICC",
            "tumorType": "localized neurofibroma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"neurofibromatosis 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Localized Neurofibroma\"\n}\n```\n\n**Changes made:**\n1. **assay**: \"ICC\" \u2192 \"immunocytochemistry\" (ICC is a common abbreviation for immunocytochemistry)\n2. **tumorType**: \"localized neurofibroma\" \u2192 \"Localized Neurofibroma\" (standardized capitalization to match the controlled terminology)\n3. **diagnosis**: No change needed (already in acceptable format)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2815,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 146
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "immunocytochemistry",
            "tumorType": "Cutaneous Neurofibroma"
          }
        },
        {
          "sample_index": 7,
          "input": {
            "diagnosis": "Neurofibromatosis-1",
            "assay": "magnetic resonance imaging",
            "tumorType": "not determined"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis-1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Changes made:**\n1. **assay**: \"magnetic resonance imaging\" \u2192 \"conventional MRI\" (standard term for general MRI in the controlled vocabulary)\n2. **tumorType**: \"not determined\" \u2192 \"Unknown\" (standard term for undetermined tumor types)\n3. **diagnosis**: \"Neurofibromatosis-1\" remains unchanged (already in standard format)",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2815,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 134
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "conventional MRI",
            "tumorType": "Unknown"
          }
        },
        {
          "sample_index": 8,
          "input": {
            "diagnosis": "NF2",
            "assay": "RNA sequencing",
            "tumorType": "benign neurilemmoma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"NF2\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n- **assay**: \"RNA sequencing\" \u2192 \"RNA-seq\" (standard terminology from the controlled vocabulary)\n- **tumorType**: \"benign neurilemmoma\" \u2192 \"Schwannoma\" (neurilemmoma is a synonym for schwannoma, which is the preferred term in the controlled vocabulary)\n- **diagnosis**: \"NF2\" remains unchanged as it's already in standard form",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2812,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 141
            },
            "attempt": 1
          },
          "score": 0.0,
          "ground_truth": {
            "diagnosis": "NF2-related schwannomatosis",
            "assay": "RNA-seq",
            "tumorType": "schwannoma"
          }
        },
        {
          "sample_index": 9,
          "input": {
            "diagnosis": "Nonmosaic NF1",
            "assay": "3D microtissue survival assay",
            "tumorType": "neurofibrosarcoma"
          },
          "response": {
            "success": true,
            "content": "```json\n{\n  \"diagnosis\": \"Nonmosaic NF1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Nonmosaic NF1\" - No change needed as this appears to be a valid diagnosis term (not in the controlled enum, so left as-is per the schema which allows any string for diagnosis).\n\n2. **assay**: \"3D microtissue survival assay\" \u2192 \"3D microtissue viability\" - These are synonymous terms referring to the same assay type. The controlled vocabulary uses \"viability\" as the standard term.\n\n3. **tumorType**: \"neurofibrosarcoma\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" - Neurofibrosarcoma is a synonym/alternative term for Malignant Peripheral Nerve Sheath Tumor (MPNST), which is the standard terminology in the controlled vocabulary.",
            "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
            "usage": {
              "input_tokens": 2823,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 254
            },
            "attempt": 1
          },
          "score": 0.043478260869565216,
          "ground_truth": {
            "diagnosis": "Neurofibromatosis type 1",
            "assay": "3D microtissue viability",
            "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
          }
        }
      ],
      "metrics": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.04481965986345472,
        "min_score": 0.0,
        "max_score": 0.18518518518518517,
        "num_scored": 10
      }
    }
  },
  "overall_metrics": {
    "total_samples": 40,
    "tasks_completed": 4,
    "tasks_failed": 0,
    "average_accuracy": 0.032707377885883605,
    "task_metrics": {
      "broadening_of_narrow_synonyms": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.026632751608899892,
        "min_score": 0.0,
        "max_score": 0.07352941176470588,
        "num_scored": 10
      },
      "correction_of_typos": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.04985289514866979,
        "min_score": 0.0,
        "max_score": 0.18518518518518517,
        "num_scored": 10
      },
      "narrowing_of_broad_synonyms": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.009524204922510007,
        "min_score": 0.0,
        "max_score": 0.0423728813559322,
        "num_scored": 10
      },
      "translation_of_exact_synonyms": {
        "total_samples": 10,
        "successful_runs": 10,
        "failed_runs": 0,
        "success_rate": 1.0,
        "average_score": 0.04481965986345472,
        "min_score": 0.0,
        "max_score": 0.18518518518518517,
        "num_scored": 10
      }
    }
  }
}